Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 20, 2026
TickeronGET DAILY SIGNALS
Why Is Aehr Test Systems (AEHR) Stock Down -7.53% Today?

Why Is Aehr Test Systems (AEHR) Stock Down -7.53% Today?

Key Takeaways

  • AEHR fell 7.53% to $44.33, a decline of $3.61 from the prior close of $47.94, extending a sharp multi-session slide.
  • No company-specific press release, SEC filing, or analyst action accompanied the move; the pressure was sector-driven.
  • Small-cap AI hardware and semiconductor test names were sold together, with photonics, power-semi, and test-equipment peers also lower.
  • The stock has now given back roughly 21% over five sessions and trades about 67% below its 52-week high of $147.40.
  • The pullback follows a Nov. 3 post-earnings pop to $65.11 that failed to hold despite record Q1 revenue of $33 million and a raised FY27 outlook of $150 million.
  • News Significance Score: 11/100 — No verified company catalyst, and a decline only modestly larger than the stock's normal daily swing.
  • Traders are watching whether the $44 area holds and whether the 200-day moving average near $74 gets reclaimed.
  • For detailed Price Targets, Earnings history, and Forecast data, explore the dedicated ticker pages.
  • Readers can also review the curated Trending AI Robots list for strategies performing best in current conditions.

Opening Summary

Aehr Test Systems (AEHR) designs and manufactures wafer-level and package-level test and burn-in systems used to qualify semiconductors — a niche that has become increasingly relevant as AI accelerators, silicon photonics, and power devices require exhaustive reliability screening. The Fremont, California-based company, which employs roughly 140 people, sells its FOX and Sonoma platforms to chipmakers, outsourced assembly partners, and hyperscale customers.

In Friday's session, the stock traded at $44.33, down $3.61 or 7.53% from Thursday's close of $47.94. The direction of the move was clearly negative, and no verified company-specific catalyst was found to explain it. The decline reflects continued de-risking across small-cap AI hardware suppliers rather than a new fundamental disclosure.

Catalyst Breakdown: Sector-Wide De-Risking in AI Hardware

The dominant driver was sector sympathy. Semiconductor test and burn-in equipment is one of the most cyclical, order-driven corners of the chip supply chain, and its small-cap constituents are being sold in tandem as investors trim exposure to AI hardware names with high revenue multiples. Peer pressure was visible across unrelated technologies: photonics, 800-volt power delivery, and burn-in testing businesses all traded lower, treated as a single basket of speculative AI-adjacent suppliers despite very different end markets.

Post-Earnings Reset Still Underway

AEHR's Nov. 3 reaction is the backdrop. Record quarterly revenue of $33.01 million — a 200% year-over-year increase — plus GAAP net income of $7.18 million and a raised fiscal 2027 revenue outlook of $150 million drove shares from $51.47 to $65.11 in a single session. That rally did not hold. Jefferies trimmed its target to $140 from $175 and Lake Street cut its to $90 from $110, both maintaining Buy ratings, while the semi-cap equipment complex saw broader multiple compression. The market has since been repricing the quarter's good news rather than disputing it.

Market Context and Trading Activity

Turnover has been running near or below the stock's recent average pace, with sessions of roughly 1.0 million to 1.5 million shares changing hands compared with a typical 2.2 million to 2.5 million, suggesting a lack of aggressive new buyers rather than heavy institutional liquidation. Liquidity is thin for a company with a market capitalization of roughly $1.45 billion, and that thinness amplifies percentage moves. The stock sits well beneath its 20-day and 60-day moving averages and below its 200-day average near $74, having broken several support levels on the way down. Broader semiconductor indices were mixed, but small-cap equipment and test names underperformed the large-cap leaders — a divergence consistent with rotation out of higher-beta suppliers.

News Significance Score

On a scale where 0 means no meaningful news and a price move that is entirely normal for the stock, and 100 means transformative news paired with an extreme, rare move, AEHR scores 11 out of 100. No company-specific disclosure, filing, or analyst action accompanied this session, and the identifiable drivers were sector-level, making them weak relative to a company that raised guidance only two weeks ago.

The price behavior was unremarkable as well. The decline was about 1.3 times the stock's typical absolute daily move of roughly 5.8%, and moves of similar or greater magnitude occurred 15 times in the last 60 sessions. Weak news and a routine-for-this-stock swing combine into a low score.

What Comes Next for AEHR

The next quarterly report, covering the December quarter, is expected in mid-January. Investors will focus on whether the $109.3 million effective backlog converts into revenue on schedule and whether gross margin holds near the 47.5% reported last quarter. The most consequential near-term milestone is customer-side: a fully configured FOX-XP wafer-level burn-in cell is scheduled for installation at a Taiwan-based assembly partner in early calendar 2027, with a decision on broader high-volume deployment expected within several months of validation. Sonoma shipments to a hyperscale customer's second AI processor ramp during 2027. Analyst consensus remains a Strong Buy with an average target near $117. Key risks include severe customer concentration, an order book that can shift quarter to quarter, a valuation still near 30 times sales, and persistent insider selling.

Trending AI Robots

Tickeron operates hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are elevated into its curated Trending AI Robots section. The bots differ widely by strategy, holding timeframe, performance metrics, and the symbols they trade, so the featured roster shifts as market conditions change. For readers tracking volatile, high-beta names like this one, that page offers a practical way to see which automated strategies are currently working and how they are positioned.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AEHR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AEHR sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for AEHR moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 73 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for AEHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.

Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 46.26B. The market cap for tickers in the group ranges from 310.74K to 665.22B. ASMLF holds the highest valuation in this group at 665.22B. The lowest valued company is SMTK at 310.74K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -7%. For the same Industry, the average monthly price growth was -20%, and the average quarterly price growth was -41%. ASYS experienced the highest price growth at -1%, while AEHR experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 24% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 44
Price Growth Rating: 63
SMR Rating: 71
Profit Risk Rating: 78
Seasonality Score: 27 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of burn-in and test equipment for semiconductor manufacturing

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
400 Kato Terrace
Phone
+1 510 623-9400
Employees
138
Web
https://www.aehr.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.